Loading clinical trials...
Loading clinical trials...
Exploring the Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors
Conditions
Interventions
Hetrombopag
Locations
1
China
Shanghai Changhai Hospital
Shanghai, China
Start Date
October 1, 2024
Primary Completion Date
July 1, 2026
Completion Date
August 1, 2026
Last Updated
March 25, 2026
Lead Sponsor
Changhai Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions